FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2909571844> ?p ?o ?g. }

• W2909571844 endingPage "e0007018" @default.
• W2909571844 startingPage "e0007018" @default.
• W2909571844 abstract "Background Cerebral sparganosis is the most serious complication of human sparganosis. Currently, there is no standard for the treatment of inoperable patients. Conventional-dose praziquantel therapy is the most reported treatment. However, the therapeutic outcomes are not very effective. High-dose praziquantel therapy is a useful therapeutic choice for many parasitic diseases that is well tolerated by patients, but it has not been sufficiently evaluated for cerebral sparganosis. This study aims to observe the prognoses following high-dose praziquantel therapy in inoperable patients and the roles of MRI and peripheral eosinophil absolute counts during follow-up. Methodology Baseline and follow-up epidemiological, clinical, radiological and therapeutic data related to 10 inoperable patients with cerebral sparganosis that were treated with repeated courses of high-dose praziquantel therapy, with each course consisting of 25 mg/kg thrice daily for 10 days were assessed, followed by analyses of the prognoses, MRI findings and peripheral eosinophil absolute counts. Principal findings Baseline clinical data: the clinical symptoms recorded included seizures, hemiparesis, headache, vomiting and altered mental status. Peripheral blood eosinophilia was found in 3 patients. The baseline radiological findings were as follows. Motile lesions were observed in 10 patients, including aggregated ring-like enhancements, tunnel signs, serpiginous and irregular enhancements. Nine of the 10 patients had varying degrees of white matter degeneration, cortical atrophy and ipsilateral ventricle dilation. The follow-up clinical data were as follows. Clinical symptom relief was found in 8 patients, symptoms were eliminated in 1 patient, and symptoms showed no change from baseline in 1 patient. Peripheral blood eosinophilia was found in 2 patients. The follow-up radiological findings were as follows. Motile lesions that were transformed into stable, chronic lesions were found in 8 patients, and motile lesions that were eliminated completely were found in 2 patients. Conclusions High-dose praziquantel therapy for cerebral sparganosis is effective. The radiological outcomes of motile lesions are an important indicator during the treatment process, especially during follow-ups after clinical symptoms have improved. Peripheral eosinophil absolute counts cannot be used as an effective prognostic indicator." @default.
• W2909571844 created "2019-01-25" @default.
• W2909571844 creator A5005186844 @default.
• W2909571844 creator A5008008825 @default.
• W2909571844 creator A5013963500 @default.
• W2909571844 creator A5020307714 @default.
• W2909571844 creator A5021587680 @default.
• W2909571844 creator A5024638516 @default.
• W2909571844 creator A5025767696 @default.
• W2909571844 creator A5029360035 @default.
• W2909571844 creator A5045874160 @default.
• W2909571844 creator A5052267876 @default.
• W2909571844 creator A5065400639 @default.
• W2909571844 date "2019-01-14" @default.
• W2909571844 modified "2023-10-18" @default.
• W2909571844 title "Follow-up study of high-dose praziquantel therapy for cerebral sparganosis" @default.
• W2909571844 cites W1518293071 @default.
• W2909571844 cites W1565616294 @default.
• W2909571844 cites W1807675074 @default.
• W2909571844 cites W1969246297 @default.
• W2909571844 cites W1979229427 @default.
• W2909571844 cites W2001346172 @default.
• W2909571844 cites W2001645855 @default.
• W2909571844 cites W2007002385 @default.
• W2909571844 cites W2020558639 @default.
• W2909571844 cites W2037404497 @default.
• W2909571844 cites W2038021955 @default.
• W2909571844 cites W2046351902 @default.
• W2909571844 cites W2047468127 @default.
• W2909571844 cites W2050217363 @default.
• W2909571844 cites W2053212416 @default.
• W2909571844 cites W2055523898 @default.
• W2909571844 cites W2056175434 @default.
• W2909571844 cites W2057871396 @default.
• W2909571844 cites W2096683465 @default.
• W2909571844 cites W2121927645 @default.
• W2909571844 cites W2166201937 @default.
• W2909571844 cites W2167712077 @default.
• W2909571844 cites W2171756276 @default.
• W2909571844 cites W2255533351 @default.
• W2909571844 cites W2530891114 @default.
• W2909571844 cites W2793672935 @default.
• W2909571844 cites W3146001890 @default.
• W2909571844 cites W4299377468 @default.
• W2909571844 cites W2125134772 @default.
• W2909571844 doi "https://doi.org/10.1371/journal.pntd.0007018" @default.
• W2909571844 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6331082" @default.
• W2909571844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30640909" @default.
• W2909571844 hasPublicationYear "2019" @default.
• W2909571844 type Work @default.
• W2909571844 sameAs 2909571844 @default.
• W2909571844 citedByCount "13" @default.
• W2909571844 countsByYear W29095718442019 @default.
• W2909571844 countsByYear W29095718442020 @default.
• W2909571844 countsByYear W29095718442021 @default.
• W2909571844 countsByYear W29095718442022 @default.
• W2909571844 countsByYear W29095718442023 @default.
• W2909571844 crossrefType "journal-article" @default.
• W2909571844 hasAuthorship W2909571844A5005186844 @default.
• W2909571844 hasAuthorship W2909571844A5008008825 @default.
• W2909571844 hasAuthorship W2909571844A5013963500 @default.
• W2909571844 hasAuthorship W2909571844A5020307714 @default.
• W2909571844 hasAuthorship W2909571844A5021587680 @default.
• W2909571844 hasAuthorship W2909571844A5024638516 @default.
• W2909571844 hasAuthorship W2909571844A5025767696 @default.
• W2909571844 hasAuthorship W2909571844A5029360035 @default.
• W2909571844 hasAuthorship W2909571844A5045874160 @default.
• W2909571844 hasAuthorship W2909571844A5052267876 @default.
• W2909571844 hasAuthorship W2909571844A5065400639 @default.
• W2909571844 hasBestOaLocation W29095718441 @default.
• W2909571844 hasConcept C126322002 @default.
• W2909571844 hasConcept C141071460 @default.
• W2909571844 hasConcept C165901193 @default.
• W2909571844 hasConcept C203014093 @default.
• W2909571844 hasConcept C2776225656 @default.
• W2909571844 hasConcept C2777129736 @default.
• W2909571844 hasConcept C2779744950 @default.
• W2909571844 hasConcept C2780394864 @default.
• W2909571844 hasConcept C2780852908 @default.
• W2909571844 hasConcept C2910083286 @default.
• W2909571844 hasConcept C71924100 @default.
• W2909571844 hasConceptScore W2909571844C126322002 @default.
• W2909571844 hasConceptScore W2909571844C141071460 @default.
• W2909571844 hasConceptScore W2909571844C165901193 @default.
• W2909571844 hasConceptScore W2909571844C203014093 @default.
• W2909571844 hasConceptScore W2909571844C2776225656 @default.
• W2909571844 hasConceptScore W2909571844C2777129736 @default.
• W2909571844 hasConceptScore W2909571844C2779744950 @default.
• W2909571844 hasConceptScore W2909571844C2780394864 @default.
• W2909571844 hasConceptScore W2909571844C2780852908 @default.
• W2909571844 hasConceptScore W2909571844C2910083286 @default.
• W2909571844 hasConceptScore W2909571844C71924100 @default.
• W2909571844 hasIssue "1" @default.
• W2909571844 hasLocation W29095718441 @default.
• W2909571844 hasLocation W29095718442 @default.
• W2909571844 hasLocation W29095718443 @default.
• W2909571844 hasLocation W29095718444 @default.
• W2909571844 hasLocation W29095718445 @default.

• next